Ofatumumab
Product Description
| Product | Ofatumumab |
| CAS | 679818-59-8 |
| Formula | C6480H10022N1742O2020S44 |
| Synonym | Arzerra, Arzerra Injection, GSK 1841157, GSK1841157, HSDB 8170, HuMax-CD20, HuMax-CD20, 2F2, Immunoglobulin G1, anti-(human CD20 (antigen))(human monoclonal HuMax-CD20 heavy chain), disulfide with human monoclonal HuMax-CD20 kappa-chain, dimer, Ofatumumab, UNII-M95KG522R0 |
Typical Product Specifications
| Molecular weight | 146100.0 Da |
| Assay/Purity | Typically NLT 98% |
| Notes | Ofatumumab is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate |
| Class | Active Pharmaceutical Ingredients (API) & Intermediates, API Product List |
| Industry | Pharmaceutical |
Find another Material
Enter a chemical name, synonym or CAS# below
